Three University of Wisconsin Stem Cell Patents Rejected
eldavojohn writes "A non-profit alumni group from the University of Wisconsin (WARF) has suffered a preliminary ruling against three of their recent patents regarding stem cells. Given that these patents have been upheld in prior rulings, there is a lot of speculation that they will be upheld in a future court case. From the PhysOrg article: 'The patents, which cover virtually all stem cell research in the country, have brought in at least $3.2 million and could net much more money before they expire in 2015, the newspaper said. Companies wanting to study the cells must buy licenses costing $75,000 to $400,000. The newspaper said WARF recently started waiving the fees if the research is conducted at universities or by non-profit groups.' Should universities (or groups within universities) be allowed to hold patents and intellectual property while at the same time gaining donations and grants as an educational institution — or for that matter government funds?"
"Should universities (or groups within universities) be allowed to hold patents and intellectual property while at the same time gaining donations and grants as an educational institution -- or for that matter government funds?"
Why not? I would prefer a university to hold a pattern any day than any corporate - at least, they are letting other NPOs and universities use it without charging.
In fact, give them more funding to do more research. Let them grab patterns before corporates get there first.
The reasons given were that the patents were:
It seems to me that some business model patents and computer patents that were accepted should have been rejected for the same reasons.
America, Home of the Brave.
I'm not too interested in the ethics or legality of obtaining patents from research funded by grants from non-governmental funding sources. That should be a contract item between the granter and grantee. But research results funded by government sources should be open and non-patentable. I've paid for the research once through my taxes. I should not have to pay for it again. Software developed using government funds should be open sourced using a BSD style license so that anyone can include it in either closed source or open source apps.
FreeSpeech.org
There is no such thing as non-profit research at a university today, at least not in the life sciences. The reasons that non-profits are licensing these things is because THEY want to patent their inventions, and sell them to industry. If they don't have a license for the original research they did, they won't be able to sell it in turn. When the federal government started to encourage universities to patent the results of research off of NIH and NSF grants, and charge licensing fees, the whole idea of non-profit basic research died a sad death. Uni's are just for-profit research entities today, teaching is nearly irrelevant (most faculty consider it a burden & waste of their time), the junior faculty don't get paid much, & the post-docs and grad students are essentially slave labor, but the Profs that bring in big grants & patents are paid as much if not more than an industry.
1984 was supposed to be a warning, not an instruction manual.
As far as alternatives to the current patent regime, the only other solutions are either government directed research or large government prize rewards. Both of these have drawbacks that far outweigh the benefit of their implementation.
The problem with direct 100% government funding is that it creates an incentive to never actually finish work. Researchers would be loathed to find a cure if that cure meant that they were no longer needed and their funding would be cut off. As an illustration, look at the War on Drugs. Do you think the DEA and FBI would actually benefit if all illegal drugs were to suddenly stop entering the US? No, they would have their funding either capped or cut.
Direct prizes are problematic b/c they are inherently hard to value. At a proper prize would have to cover the cost of research plus a "healthy" profit to get companies to compete for it. The hard part here comes in determining the valuation. If the prize amount is set too low, no one will do research. If it is set too high, you effectively have society overpaying for the drug, the excess being the prize amount minus the minimum amount the winning company would have accepted. All of this guessing is eliminated in a patent regime, as the market will determine the amount spent on research, while the patent will effectively serve as "the carrot" for which the drug company will be awarded.
The sun beams down on a brand new day, No more welfare tax to pay, Unsightly slums gone up in flashing light...